Dysfunction of the anterior pituitary following traumatic brain injury: A prospective longitudinal study

2007 ◽  
Vol 115 (S 1) ◽  
Author(s):  
A Kleindienst ◽  
D Weigel ◽  
C Bock ◽  
G Brabant ◽  
M Buchfelder
PEDIATRICS ◽  
2009 ◽  
Vol 124 (6) ◽  
pp. e1064-e1071 ◽  
Author(s):  
V. Anderson ◽  
C. Catroppa ◽  
S. Morse ◽  
F. Haritou ◽  
J. V. Rosenfeld

Brain Injury ◽  
2010 ◽  
Vol 24 (13-14) ◽  
pp. 1528-1538 ◽  
Author(s):  
Joan Norrie ◽  
Marcus Heitger ◽  
Janet Leathem ◽  
Tim Anderson ◽  
Richard Jones ◽  
...  

BMJ Open ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. e042093
Author(s):  
Neil Samuel Nyholm Graham ◽  
Karl A Zimmerman ◽  
Guido Bertolini ◽  
Sandra Magnoni ◽  
Mauro Oddo ◽  
...  

Introduction and aimsTraumatic brain injury (TBI) often results in persistent disability, due particularly to cognitive impairments. Outcomes remain difficult to predict but appear to relate to axonal injury. Several new approaches involving fluid and neuroimaging biomarkers show promise to sensitively quantify axonal injury. By assessing these longitudinally in a large cohort, we aim both to improve our understanding of the pathophysiology of TBI, and provide better tools to predict clinical outcome.Methods and analysisBIOmarkers of AXonal injury after TBI is a prospective longitudinal study of fluid and neuroimaging biomarkers of axonal injury after moderate-to-severe TBI, currently being conducted across multiple European centres. We will provide a detailed characterisation of axonal injury after TBI, using fluid (such as plasma/microdialysate neurofilament light) and neuroimaging biomarkers (including diffusion tensor MRI), which will then be related to detailed clinical, cognitive and functional outcome measures. We aim to recruit at least 250 patients, including 40 with cerebral microdialysis performed, with serial assessments performed twice in the first 10 days after injury, subacutely at 10 days to 6 weeks, at 6 and 12 months after injury.Ethics and disseminationThe relevant ethical approvals have been granted by the following ethics committees: in London, by the Camberwell St Giles Research Ethics Committee; in Policlinico (Milan), by the Comitato Etico Milano Area 2; in Niguarda (Milan), by the Comitato Etico Milano Area 3; in Careggi (Florence), by the Comitato Etico Regionale per la Sperimentazione Clinica della Regione Toscana, Sezione area vasta centro; in Trento, by the Trento Comitato Etico per le Sperimentazioni Cliniche, Azienda Provinciale per i Servizi Sanitari della Provincia autonoma di Trento; in Lausanne, by the Commission cantonale d’éthique de la recherche sur l’être humain; in Ljubljana, by the National Medical Ethics Committee at the Ministry of Health of the Republic of Slovenia. The study findings will be disseminated to patients, healthcare professionals, academics and policy-makers including through presentation at conferences and peer-reviewed publications. Data will be shared with approved researchers to provide further insights for patient benefit.Trial registration numberNCT03534154.


2016 ◽  
Vol 20 (7) ◽  
pp. 456-461 ◽  
Author(s):  
Agata Krasny-Pacini ◽  
Leila Francillette ◽  
Hanna Toure ◽  
Dominique Brugel ◽  
Anne Laurent-Vannier ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document